SCHEMBL2015054

SCHEMBL2015054

COc1ccc2[nH]c(C(=O)N(C)C(CCNC(=O)c3cccn3C)Cc3ccccc3)cc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.60
HCRTR2 O43614 1/20 0.60
KDM4E B2RXH2 6/20 0.54
MAPT P10636 3/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
PYGL P06737 1/20 0.53
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 2/20 0.45
DRD3 P35462 2/20 0.45
DRD4 P21917 1/20 0.45
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
RXFP1 Q9HBX9 1/20 0.44
HTR1A P08908 1/20 0.44
DRD2 P14416 1/20 0.44
HTR2A P28223 1/20 0.44
FLT3 P36888 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015645 0.90 HCRTR1 (0.59) HCRTR1HCRTR2KDM4EMAPTNPC1
SCHEMBL2052696 0.90 HCRTR1 (0.59) HCRTR1HCRTR2KDM4EMAPTNPC1
SCHEMBL2012240 0.89 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9APYGL
SCHEMBL2012867 0.84 HCRTR1 (0.59) HCRTR1HCRTR2KDM4EMAPTNPC1
SCHEMBL2012866 0.84 HCRTR1 (0.59) HCRTR1HCRTR2KDM4EMAPTNPC1
SCHEMBL13139074 0.83 HCRTR1 (0.84) HCRTR1HCRTR2KDM4ENPC1RAB9A
SCHEMBL13139077 0.83 HCRTR1 (0.75) HCRTR1HCRTR2MAPTNPC1RAB9A
SCHEMBL2010990 0.82 HCRTR1 (0.58) HCRTR1HCRTR2KDM4EMAPTNPC1
SCHEMBL2011939 0.82 HCRTR1 (0.58) HCRTR1HCRTR2KDM4EMAPTNPC1
SCHEMBL2016380 0.81 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed